Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05591703 · ClinicalTrials.gov registry record
Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study
A clinical trial, sponsored by Spark Biomedical.
- Completed
- Registry status
- 32
- Enrollment target
NCT05591703: Completed study, sponsored by Spark Biomedical.
NCT05591703 is a clinical trial that has completed, run by Spark Biomedical. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05591703 has completed, sponsored by Spark Biomedical.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This is a prospective, observational, longitudinal study to assess clinical outcomes in the 12-months following participants' exit from protocol SBM-OWP-03, Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (RESTORE; ClinicalTrials.gov Identifier: NCT05053503). Clinical outcome scores will be collected at study exit from protocol SBM-OWP-03, 1 month, 3 months, 6 months, 9 months, and 12 months after study exit from protocol SBM-OWP-03.
Interventions
- BEHAVIORAL Clinical Outcomes and Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-11-21 |
| Est. Completion | 2025-01-31 |
What the finished NCT05591703 record still lists
NCT05591703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Clinical Outcomes and Questionnaires is the first listed.
NCT05591703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05591703 about?
NCT05591703 is a clinical study titled "Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study". This is a prospective, observational, longitudinal study to assess clinical outcomes in the 12-months following participants' exit from protocol SBM-OWP-03, Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (RESTORE; ClinicalTrials.gov Identifi...
What is the current status of trial NCT05591703?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2022-11-21. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT05591703?
The interventions under investigation include: Clinical Outcomes and Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT05591703?
This trial is sponsored by Spark Biomedical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI